Corrective and Preventive Action
Contents
Corrective and Preventive Action#
ISO 13485:2016 Section |
Document Section |
---|---|
8.5.1 |
(All) |
8.5.2 |
(All) |
8.5.3 |
(All) |
Summary#
This SOP describes how CAPAs are implemented and tracked.
Process Steps#
1. Input for CAPA#
Various events may lead to creation of CAPA. Examples include:
Product or QMS non-conformities
Customer complaints
Internal bug reports, e.g. by developers
Audit findings
Post-market surveillance findings, including trends
Management review findings, including trends
These inputs may be received from any person inside or outside the company. The QMO is responsible for creating the CAPA and tracking its resolution.
CAPAs are tracked in the CAPA list.
Participants |
---|
QMO |
Input |
Output |
---|---|
Non-conformity, complaint, etc. |
CAPA created |
2. Decision on Next Steps, Immediate Action#
If immediate action is necessary (e.g. product recall, notification of authorities), the QMO consults the Person Responsible for Regulatory Compliance. Immediate action is carried out without undue delay (see ISO 13485 para. 8.5.2).
In any case, the QMO discusses the next steps with the person closest to the issue, e.g. for software bugs, the Head of Software Development.
Participants |
---|
QMO |
Medical Device Safety Officer / Person Responsible for Regulatory Compliance (optional) |
Input |
Output |
---|---|
CAPA |
CAPA, updated with action |
3. Root Cause Analysis#
The QMO coordinates a root cause analysis with the person closest to the issue. The preferred method for this is Five Whys. The result is added to the CAPA list.
Participants |
---|
QMO |
Other people in company (optional) |
Input |
Output |
---|---|
CAPA |
CAPA, updated with root cause |
4. Implementation of Action#
The QMO coordinates defining and implementing corrective and preventive action. Additionally, the QMO takes into account adverse negative implications and verifies that the actions do not adversely affect the ability to meet applicable regulatory requirements or the safety and performance of the medical device. Outcomes are documented in the CAPA list.
Participants |
---|
QMO |
Other people in company (optional) |
Input |
Output |
---|---|
CAPA |
CAPA, updated with action plan |
5. Verification and Check of Effectiveness#
The QMO conducts the verification and effectiveness review of the implemented action. These are defined as below. Thereafter, the QMO closes the CAPA.
Verification: Documenting proof of implementation of actions taken.
Effectiveness: Review of the effectiveness of actions taken.
Participants |
---|
QMO |
Input |
Output |
---|---|
CAPA |
CAPA, updated with verification, effectiveness review, closed date |